| scholarly article | Q13442814 |
| P2093 | author name string | H Zhang | |
| S Spiegel | |||
| T Seki | |||
| A Olivera | |||
| G Brooker | |||
| N N Desai | |||
| P2860 | cites work | Sphingosine kinase in blood platelets | Q28240675 |
| Arachidonic acid metabolism | Q28287622 | ||
| The molecular heterogeneity of protein kinase C and its implications for cellular regulation | Q29619947 | ||
| Studies and perspectives of protein kinase C. | Q34162282 | ||
| Calcium wave evoked by activation of endogenous or exogenously expressed receptors in Xenopus oocytes | Q37735438 | ||
| Signaling through phosphatidylcholine breakdown. | Q37806652 | ||
| An update of the enzymology and regulation of sphingomyelin metabolism | Q37923512 | ||
| Functions of sphingolipids and sphingolipid breakdown products in cellular regulation | Q38597926 | ||
| Modulation of protein kinase C and diverse cell functions by sphingosine--a pharmacologically interesting compound linking sphingolipids and signal transduction | Q38598657 | ||
| Glycosphingolipids: structure, biological source, and properties | Q38766443 | ||
| Early signals in the mitogenic response | Q39504519 | ||
| Sphingolipid base metabolism. Partial purification and properties of sphinganine kinase of brain | Q40002151 | ||
| Inositol trisphosphate and diacylglycerol as second messengers | Q40094697 | ||
| Lack of association of epidermal growth factor-, insulin-, and serum-induced mitogenesis with stimulation of phosphoinositide degradation in BALB/c 3T3 fibroblasts | Q41363986 | ||
| Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses | Q41382443 | ||
| Phospholipase D catalyzes phospholipid metabolism in chemotactic peptide-stimulated HL-60 granulocytes | Q41395569 | ||
| Growth factor-like action of phosphatidic acid | Q41472962 | ||
| Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation | Q41700006 | ||
| Increases in phosphatidic acid levels accompany sphingosine-stimulated proliferation of quiescent Swiss 3T3 cells | Q41710971 | ||
| Ceramide 1-phosphate, a novel phospholipid in human leukemia (HL-60) cells. Synthesis via ceramide from sphingomyelin | Q41721938 | ||
| Intracellular calcium release mediated by sphingosine derivatives generated in cells | Q41730318 | ||
| Sphingosine stimulates cellular proliferation via a protein kinase C-independent pathway | Q41748195 | ||
| Early changes in inositol lipids and their metabolites induced by platelet-derived growth factor in quiescent Swiss mouse 3T3 cells | Q41864773 | ||
| A specific enhancing effect of N,N-dimethylsphingosine on epidermal growth factor receptor autophosphorylation. Demonstration of its endogenous occurrence (and the virtual absence of unsubstituted sphingosine) in human epidermoid carcinoma A431 cell | Q42068240 | ||
| A facile enzymatic synthesis of sphingosine-1-phosphate and dihydrosphingosine-1-phosphate | Q42153936 | ||
| Possible involvement of a GTP-binding protein in a late event during endogenous ganglioside-modulated cellular proliferation | Q42798858 | ||
| Ca2+ and pH responses to sequential additions of mitogens in single 3T3 fibroblasts: correlations with DNA synthesis. | Q42802830 | ||
| Mitogenesis of 3T3 fibroblasts induced by endogenous ganglioside is not mediated by cAMP, protein kinase C, or phosphoinositides turnover | Q42803125 | ||
| Cellular ras activity and phospholipid metabolism | Q42805155 | ||
| Inositol trisphosphate formation and calcium mobilization in Swiss 3T3 cells in response to platelet-derived growth factor | Q42818159 | ||
| Assay of inorganic and organic phosphorus in the 0.1–5 nanomole range | Q44547330 | ||
| Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots | Q48919839 | ||
| Metabolism of sphingosine bases. 13. Enzymatic synthesis of 1-phosphate esters of 4t-sphingenine (sphingosine), sphinganine (dihydrosphingosine), 4-hydroxysphinganine (phytosphingosine) and 3-dehydrosphinganine by erythrocytes. | Q53782925 | ||
| A ceramide analogue inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesis | Q68544672 | ||
| Modulation of the free sphingosine levels in human neutrophils by phorbol esters and other factors | Q70391574 | ||
| Enzymatic Formation of Dihydrosphingosine 1-Phosphate | Q71473185 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 155-167 | |
| P577 | publication date | 1991-07-01 | |
| P1433 | published in | Journal of Cell Biology | Q1524550 |
| P1476 | title | Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation | |
| P478 | volume | 114 |
| Q34593159 | "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets |
| Q37305365 | 1-O-acylceramides are natural components of human and mouse epidermis |
| Q44927619 | A novel approach for preventing esophageal stricture formation: sphingosylphosphorylcholine-enhanced tissue remodeling |
| Q42804390 | ATP-dependent choline phosphate-induced mitogenesis in fibroblasts involves activation of pp70 S6 kinase and phosphatidylinositol 3'-kinase through an extracellular site. Synergistic mitogenic effects of choline phosphate and sphingosine 1-phosphate |
| Q47947326 | Aberrant sphingolipid metabolism in the human fallopian tube with ectopic pregnancy |
| Q39215469 | Ablation of sphingosine kinase-2 inhibits tumor cell proliferation and migration |
| Q41989817 | Accumulation of phosphorylated sphingoid long chain bases results in cell growth inhibition in Saccharomyces cerevisiae |
| Q42992854 | Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells |
| Q41151107 | Adiponectin and its Hydrolase-Activated Receptors |
| Q27310161 | Alkaline Ceramidase 3 Deficiency Results in Purkinje Cell Degeneration and Cerebellar Ataxia Due to Dyshomeostasis of Sphingolipids in the Brain |
| Q45129798 | Altered de novo sphingolipid biosynthesis is involved in the serum deprivation-induced cell death in LLC-PK1 cells |
| Q58604755 | An update on sphingosine-1-phosphate receptor 1 modulators |
| Q73186728 | Analysis of ceramide 1-phosphate and sphingosine-1-phosphate phosphatase activities |
| Q39494222 | Analysis of phosphorylated sphingolipid long-chain bases reveals potential roles in heat stress and growth control in Saccharomyces. |
| Q73186722 | Assaying sphingosine kinase activity |
| Q78428565 | B-5354a, b and c, New Sphingosine Kinase Inhibitors, Produced by a Marine Bacterium. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Structure Determination. |
| Q37396760 | Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders |
| Q37141279 | Binding Characteristics of Sphingosine-1-Phosphate to ApoM hints to Assisted Release Mechanism via the ApoM Calyx-Opening. |
| Q70870850 | Biosynthesis of N-acetylsphingosine by platelet-activating factor: sphingosine CoA-independent transacetylase in HL-60 cels |
| Q41199299 | Ca2+ mobilizing action of sphingosine in Jurkat human leukemia T cells. Evidence that sphingosine releases Ca2+ from inositol trisphosphate- and phosphatidic acid-sensitive intracellular stores through a mechanism independent of inositol trisphospha |
| Q71737267 | Calcium signalling by G protein-coupled sphingolipid receptors in bovine aortic endothelial cells |
| Q42830058 | Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases |
| Q24653552 | Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate |
| Q46400730 | Ceramide 1-phosphate phosphatase activity in brain |
| Q73186716 | Ceramide kinase |
| Q35084457 | Ceramide structure predicts tumor ganglioside immunosuppressive activity |
| Q35740323 | Ceramide-1-phosphate: a novel regulator of cell activation |
| Q33720344 | Characterization and Expression of Sphingosine 1-Phosphate Receptors in Human and Rat Heart |
| Q44409392 | Characterization of Serine Palmitoyltransferase in Normal Human Tissues |
| Q28214577 | Characterization of a human sphingosine-1-phosphate receptor gene (S1P5) and its differential expression in LGL leukemia |
| Q28483643 | Characterization of isoenzyme-selective inhibitors of human sphingosine kinases |
| Q42805853 | Cis-4-methylsphingosine phosphate induces apoptosis in neuroblastoma cells by opposite effects on p38 and ERK mitogen-activated protein kinases |
| Q24319856 | Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? |
| Q44433921 | Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma |
| Q27644028 | Crystal structure of YegS, a homologue to the mammalian diacylglycerol kinases, reveals a novel regulatory metal binding site |
| Q36764024 | Current perspectives on FTY720. |
| Q39835135 | Decrease of Tau hyperphosphorylation by 17β estradiol requires sphingosine kinase in a glutamate toxicity model. |
| Q40755466 | Deficiency of sphingosine-1-phosphate lyase impairs lysosomal metabolism of the amyloid precursor protein |
| Q44009044 | Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes |
| Q30417604 | Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors |
| Q38335935 | Different signaling pathway between sphingosine-1-phosphate and lysophosphatidic acid in Xenopus oocytes: functional coupling of the sphingosine-1-phosphate receptor to PLC-xbeta in Xenopus oocytes |
| Q41932606 | Differential Roles of de Novo Sphingolipid Biosynthesis and Turnover in the “Burst” of Free Sphingosine and Sphinganine, and Their 1-Phosphates and N-Acyl-Derivatives, That Occurs upon Changing the Medium of Cells in Culture |
| Q41079756 | Differential effects of sphingomyelinase and cell-permeable ceramide analogs on proliferation of Swiss 3T3 fibroblasts |
| Q71907697 | Differential effects of synthetic sphingosine derivatives on melanoma cell motility, growth, adhesion and invasion in vitro |
| Q28138229 | Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5 |
| Q37830235 | Dissecting the role of the S1P/S1PR axis in health and disease. |
| Q77780124 | Diversity and complexity of ceramide signalling in apoptosis |
| Q36256204 | Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival |
| Q34389208 | Effect of acidic phospholipids on sphingosine kinase |
| Q41991229 | Effect of sphingosine derivatives on calcium fluxes in thyroid FRTL-5 cells |
| Q41533197 | Emptying of intracellular Ca2+ stores releases a novel small messenger that stimulates Ca2+ influx |
| Q30439954 | Engineering vascularized tissues using natural and synthetic small molecules |
| Q40646901 | Enhanced Serine Palmitoyltransferase Expression in Proliferating Fibroblasts, Transformed Cell Lines, and Human Tumors |
| Q36118256 | Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling. |
| Q40843502 | Enzymatic method for measurement of sphingosine 1-phosphate |
| Q41015800 | Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins |
| Q37408557 | Export and functions of sphingosine-1-phosphate. |
| Q27009557 | Export of sphingosine-1-phosphate and cancer progression |
| Q41832728 | Extracellular sphingosine 1-phosphate stimulates formation of ethanolamine from phosphatidylethanolamine: modulation of sphingosine 1-phosphate-induced mitogenesis by ethanolamine |
| Q74044934 | F-12509A, a new sphingosine kinase inhibitor, produced by a discomycete |
| Q36052555 | FTY720 suppresses interleukin-1beta-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism |
| Q91964712 | Fingolimod Plays Role in Attenuation of Myocardial Injury Related to Experimental Model of Cardiac Arrest and Extracorporeal Life Support Resuscitation |
| Q55285115 | First evidence of SGPL1 expression in the cell membrane silencing the extracellular S1P siren in mammary epithelial cells. |
| Q49014246 | Functional expression and signaling properties of cloned human parathyroid hormone receptor in Xenopus oocytes. Evidence for a novel signaling pathway |
| Q31640177 | Functions of a new family of sphingosine-1-phosphate receptors |
| Q47174627 | G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts |
| Q35824021 | Ganglioside/glycosphingolipid turnover: new concepts |
| Q42205646 | Gelsolin and functionally similar actin-binding proteins are regulated by lysophosphatidic acid |
| Q34361286 | Glial cell responses to lipids bound to albumin in serum and plasma |
| Q33808022 | Growth-limiting role of endothelial cells in endoderm development |
| Q39392240 | H-Ras increases release of sphingosine resulting in down-regulation of TSP-1 in non-transformed cells. |
| Q41871959 | Heterologous desensitization of the sphingosine-1-phosphate receptors by purinoceptor activation in renal mesangial cells |
| Q90655362 | Human Remyelination Promoting Antibody Stimulates Astrocytes Proliferation Through Modulation of the Sphingolipid Rheostat in Primary Rat Mixed Glial Cultures |
| Q40471900 | Human placental lipid induces melanogenesis by increasing the expression of tyrosinase and its related proteins in vitro. |
| Q44044901 | Human placental lipid induces mitogenesis and melanogenesis in B16F10 melanoma cells |
| Q22254319 | Human sphingosine kinase: molecular cloning, functional characterization and tissue distribution |
| Q42066158 | Identification and subcellular localization of sphinganine-phosphatases in rat liver |
| Q24316056 | Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids |
| Q73487746 | Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate |
| Q36898368 | Implication of sphingosin-1-phosphate in cardiovascular regulation |
| Q39396610 | Induction of Ca2+ oscillations by selective, U73122-mediated, depletion of inositol-trisphosphate-sensitive Ca2+ stores in rabbit pancreatic acinar cells. |
| Q64038867 | Influence of lipid diets on the number of metastases and ganglioside content of H59 variant tumors |
| Q40870274 | Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate |
| Q41272671 | Interaction of Ceramides, Sphingosine, and Sphingosine 1-Phosphate in Regulating DNA Synthesis and Phospholipase D Activity |
| Q45919951 | Intracellular IL-15 controls mast cell survival. |
| Q28743138 | Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase |
| Q42806506 | Involvement of sphingolipids metabolites in cellular proliferation modulated by ganglioside GM1. |
| Q33808769 | Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1-phosphate generation |
| Q45177699 | Janus kinase 3: a novel target for selective transplant immunosupression |
| Q24657671 | Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1 |
| Q64098656 | Links between accelerated replicative cellular senescence and down-regulation of SPHK1 transcription |
| Q36282427 | Lipidomic approach for stratification of acute myeloid leukemia patients |
| Q30424618 | Local delivery of FTY720 accelerates cranial allograft incorporation and bone formation |
| Q47233200 | Lysophosphatidic Acid Signaling Axis Mediates Ceramide 1-Phosphate-Induced Proliferation of C2C12 Myoblasts |
| Q42540355 | Lysophosphatidic acid stimulates the G-protein-coupled receptor EDG-1 as a low affinity agonist |
| Q42131433 | Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis. |
| Q37173208 | Lysophospholipid receptors in vertebrate development, physiology, and pathology |
| Q93370188 | Metabolic pathways modulate the neuronal toxicity associated with fragile X-associated tremor/ataxia syndrome |
| Q57364601 | Metabolism and physiological functions of sphingolipids |
| Q34747143 | Mitochondria and ceramide: intertwined roles in regulation of apoptosis |
| Q41728046 | Modulation of cell signalling by ceramides. |
| Q37707542 | Molecular cloning and characterization of SCaMPER, a sphingolipid Ca2+ release-mediating protein from endoplasmic reticulum |
| Q77998315 | N-acetyl-sphingenine-1-phosphate is a potent calcium mobilizing agent |
| Q36881675 | New insights into glycosphingolipid functions--storage, lipid rafts, and translocators |
| Q72134308 | On the presence of phosphorylated sphingoid bases in rat tissues. A mass-spectrometric approach |
| Q37070994 | PDGF induces SphK1 expression via Egr-1 to promote pulmonary artery smooth muscle cell proliferation |
| Q41093160 | Pertussis toxin- and PMA-insensitive calcium mobilization by sphingosine in CFPAC-1 cells: evidence for a phosphatidic acid-dependent mechanism |
| Q30410634 | Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors |
| Q58691421 | Phospholipid and Lipid Derivatives as Potential Neuroprotective Compounds |
| Q42826788 | Phosphorylated cis-4-methylsphingosine mimics the mitogenic effect of sphingosine-1-phosphate in Swiss 3T3 fibroblasts |
| Q33930354 | Physiology and pathophysiology of sphingolipid metabolism and signaling |
| Q35146936 | Pleiotropic actions of sphingosine-1-phosphate |
| Q42467452 | Predominance of the acylation route in the metabolic processing of exogenous sphingosine in neural and extraneural cells in culture |
| Q74182787 | Prenatal alcohol exposure increases TNFalpha-induced cytotoxicity in primary astrocytes |
| Q36727326 | Protein kinase C-epsilon regulates sphingosine 1-phosphate-mediated migration of human lung endothelial cells through activation of phospholipase D2, protein kinase C-zeta, and Rac1. |
| Q34559806 | Regulating survival and development in the retina: key roles for simple sphingolipids |
| Q36715339 | Regulation and functional roles of sphingosine kinases |
| Q48128990 | Regulation of mitogen-activated protein kinases by sphingolipid products in oligodendrocytes. |
| Q40890957 | Regulation of proliferation and apoptosis by Ras and Rho GTPases through specific phospholipid-dependent signaling |
| Q37415111 | Regulation of vascular physiology and pathology by the S1P2 receptor subtype. |
| Q38358894 | Regulatory role of ceramide in interleukin (IL)-1 beta-induced E-selectin expression in human umbilical vein endothelial cells. Ceramide enhances IL-1 beta action, but is not sufficient for E-selectin expression |
| Q36553395 | Reminiscence of our research on membrane phospholipids in mammalian cells by using the novel technology |
| Q30464665 | Responses to sphingosine-1-phosphate in X. laevis oocytes: similarities with lysophosphatidic acid signaling |
| Q26996672 | Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy |
| Q51606648 | Rheumatology mini focus. |
| Q74546220 | Role of nitric oxide and its intracellular signalling pathways in the control of Ca2+ homeostasis |
| Q34017124 | Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro. |
| Q35047120 | Roles of phospholipase D in apoptosis and pro-survival |
| Q34879183 | Roles of sphingosine 1-phosphate on tumorigenesis |
| Q37699303 | Roles of sphingosine-1-phosphate in reproduction |
| Q39169246 | Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis. |
| Q33886533 | S1P metabolism in cancer and other pathological conditions |
| Q42720652 | S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition |
| Q89655256 | S1PR1-Associated Molecular Signature Predicts Survival in Patients with Sepsis |
| Q53644116 | SEW2871 protects from experimental colitis through reduced epithelial cell apoptosis and improved barrier function in interleukin-10 gene-deficient mice. |
| Q35160719 | Scientific literature on monosialoganglioside in the Science Citation Index-Expanded: A bibliometric analysis of articles from 1942 to 2011 by each decade |
| Q34419066 | Separation of fluorescently labeled phosphoinositides and sphingolipids by capillary electrophoresis |
| Q38367296 | Signal transduction in inherited metabolic disorders: a model for a possible pathogenetic mechanism |
| Q36232949 | Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts |
| Q27934999 | Sli2 (Ypk1), a homologue of mammalian protein kinase SGK, is a downstream kinase in the sphingolipid-mediated signaling pathway of yeast |
| Q42799069 | Sphinganine 1-phosphate metabolism in cultured skin fibroblasts: evidence for the existence of a sphingosine phosphatase. |
| Q35670314 | Sphingoid base 1-phosphate phosphatase: a key regulator of sphingolipid metabolism and stress response. |
| Q40654735 | Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity |
| Q35324757 | Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics |
| Q33695125 | Sphingolipid metabolism in the regulation of bioactive molecules |
| Q40950086 | Sphingolipid metabolites: members of a new class of lipid second messengers |
| Q36843303 | Sphingolipid profile alters in retinal dystrophic P23H-1 rats and systemic FTY720 can delay retinal degeneration |
| Q35675184 | Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond |
| Q41360689 | Sphingolipid-gated Ca2+ release from intracellular stores of endothelial cells is mediated by a novel Ca(2+)-permeable channel |
| Q89977951 | Sphingolipids and Mitochondrial Dynamic |
| Q28084945 | Sphingolipids as cell fate regulators in lung development and disease |
| Q41531632 | Sphingolipids as mediators of effects of platelet-derived growth factor in vascular smooth muscle cells |
| Q27026103 | Sphingolipids in spinal cord injury |
| Q33911965 | Sphingomyelin metabolites in vascular cell signaling and atherogenesis |
| Q47881999 | Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair. |
| Q43559665 | Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells |
| Q44932630 | Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses |
| Q36890026 | Sphingosine 1-phosphate potentiates human lung fibroblast chemotaxis through the S1P2 receptor |
| Q79291156 | Sphingosine 1-phosphate protects rat liver sinusoidal endothelial cells from ethanol-induced apoptosis: Role of intracellular calcium and nitric oxide |
| Q29013537 | Sphingosine 1-phosphate receptors |
| Q33958247 | Sphingosine 1-phosphate signalling in mammalian cells |
| Q34126142 | Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors |
| Q41122787 | Sphingosine 1-phosphate stimulates Na+/H+ exchange in thyroid FRTL-5 cells |
| Q42800311 | Sphingosine 1-phosphate stimulates rho-mediated tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 fibroblasts |
| Q35503361 | Sphingosine 1-phosphate, a diffusible calcium influx factor mediating store-operated calcium entry. |
| Q34128454 | Sphingosine 1-phosphate, a key cell signaling molecule |
| Q37249572 | Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness |
| Q22011004 | Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5 |
| Q28297208 | Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218 |
| Q34233389 | Sphingosine 1-phosphate: synthesis and release |
| Q41531207 | Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System |
| Q59192165 | Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte |
| Q41240589 | Sphingosine and sphingosine 1-phosphate differentially modulate platelet-derived growth factor-BB-induced Ca2+ signaling in transformed oligodendrocytes |
| Q33853998 | Sphingosine kinase 1 in cancer |
| Q39168123 | Sphingosine kinase 1 overexpression stimulates intestinal epithelial cell proliferation through increased c-Myc translation |
| Q36294755 | Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. |
| Q36060030 | Sphingosine kinase signalling in immune cells |
| Q35047178 | Sphingosine kinase, sphingosine-1-phosphate, and apoptosis |
| Q28185880 | Sphingosine kinase: a mediator of vital cellular functions |
| Q34725633 | Sphingosine kinases: a novel family of lipid kinases |
| Q55564395 | Sphingosine-1-Phosphate-Specific G Protein-Coupled Receptors as Novel Therapeutic Targets for Atherosclerosis. |
| Q47825992 | Sphingosine-1-phosphate as an intercellular signaling molecule. |
| Q42805681 | Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens |
| Q26852824 | Sphingosine-1-phosphate in chronic intestinal inflammation and cancer |
| Q35086003 | Sphingosine-1-phosphate induces pro-remodelling response in airway smooth muscle cells |
| Q36235805 | Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction |
| Q44371529 | Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages |
| Q71034353 | Sphingosine-1-phosphate inhibits actin nucleation and pseudopodium formation to control cell motility of mouse melanoma cells |
| Q38935993 | Sphingosine-1-phosphate inhibits differentiation of C3H10T1/2 cells into adipocyte |
| Q44648524 | Sphingosine-1-phosphate inhibits human keratinocyte proliferation via Akt/protein kinase B inactivation |
| Q54342529 | Sphingosine-1-phosphate mediates epidermal growth factor-induced muscle satellite cell activation. |
| Q42444888 | Sphingosine-1-phosphate promotes mouse melanocyte survival via ERK and Akt activation |
| Q41065014 | Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor |
| Q37413862 | Sphingosine-1-phosphate receptor signalling in the heart |
| Q37317783 | Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease |
| Q42525224 | Sphingosine-1-phosphate stimulates human Caco-2 intestinal epithelial proliferation via p38 activation and activates ERK by an independent mechanism |
| Q40607042 | Sphingosine-1-phosphate, a novel second messenger involved in cell growth regulation and signal transduction, affects growth and invasiveness of human breast cancer cells |
| Q90117111 | Sphingosine-1-phosphate: From insipid lipid to a key regulator |
| Q29620563 | Sphingosine-1-phosphate: an enigmatic signalling lipid |
| Q34980697 | Sphingosine-1-phosphate: dual messenger functions |
| Q33957118 | Sphingosine-1-phosphate: signaling inside and out. |
| Q41153301 | Sphingosine-induced inhibition of capacitative calcium influx in CFPAC-1 cells |
| Q42985690 | Sphingosylphosphocholine modulates the ryanodine receptor/calcium-release channel of cardiac sarcoplasmic reticulum membranes |
| Q42445967 | Sphingosylphosphorylcholine activates an amiloride-insensitive Na+-H+-exchange mechanism in GH4C1 cells |
| Q41656256 | Sphingosylphosphorylcholine is a remarkably potent mitogen for a variety of cell lines |
| Q35377676 | Spinster homolog 2 (spns2) deficiency causes early onset progressive hearing loss |
| Q42798604 | Stimulation of DNA synthesis by natural ceramide 1-phosphate |
| Q42826338 | Stimulation of nuclear sphingosine kinase activity by platelet-derived growth factor |
| Q38204271 | Structural biology of the S1P1 receptor |
| Q37160896 | Subcellular origin of sphingosine 1-phosphate is essential for its toxic effect in lyase-deficient neurons |
| Q34264490 | Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator |
| Q42556020 | Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate |
| Q47982503 | Survival by Mac-1-mediated adherence and anoikis in phorbol ester-treated HL-60 cells |
| Q42823251 | Synthesis and evaluation of a photolyzable derivative of sphingosine 1-phosphate--caged SPP. |
| Q34255382 | Systemic distribution, subcellular localization and differential expression of sphingosine-1-phosphate receptors in benign and malignant human tissues |
| Q38116071 | Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases |
| Q34364844 | Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond |
| Q26748848 | The SphKs/S1P/S1PR1 axis in immunity and cancer: more ore to be mined |
| Q36790267 | The apolipoprotein m-sphingosine-1-phosphate axis: biological relevance in lipoprotein metabolism, lipid disorders and atherosclerosis |
| Q27657731 | The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen |
| Q42982087 | The differential regulation of cyclic AMP by sphingomyelin-derived lipids and the modulation of sphingolipid-stimulated extracellular signal regulated kinase-2 in airway smooth muscle |
| Q27935031 | The dihydrosphingosine-1-phosphate phosphatases of Saccharomyces cerevisiae are important regulators of cell proliferation and heat stress responses |
| Q33918545 | The electrostatics of lipid surfaces |
| Q45287768 | The endocannabinoid anandamide induces apoptosis of rat decidual cells through a mechanism involving ceramide synthesis and p38 MAPK activation |
| Q30430805 | The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720. |
| Q40963836 | The identification of myriocin-binding proteins |
| Q38738515 | The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells |
| Q37293864 | The influence of sphingosine-1-phosphate receptor signaling on lymphocyte trafficking: how a bioactive lipid mediator grew up from an "immature" vascular maturation factor to a "mature" mediator of lymphocyte behavior and function. |
| Q34486205 | The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation |
| Q73212884 | The mycotoxin fumonisin B1 inhibits integrin-mediated cell-matrix adhesion |
| Q41769614 | The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways. |
| Q36011196 | The outs and the ins of sphingosine-1-phosphate in immunity |
| Q42830767 | The potent lipid mitogen sphingosylphosphocholine activates the DNA binding activity of upstream stimulating factor (USF), a basic helix-loop-helix-zipper protein |
| Q90318251 | The role of dihydrosphingolipids in disease |
| Q37928817 | The role of sphingolipids in respiratory disease |
| Q37128721 | The role of sphingosine-1-phosphate and its receptors in asthma |
| Q36241051 | The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. |
| Q36415172 | The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function |
| Q37402927 | The therapeutic potential of novel cannabinoid receptors |
| Q83324534 | Transcriptional activation of tyrosinase gene by human placental sphingolipid |
| Q73426568 | Tumor necrosis factor-alpha-mediated signal transduction in human neutrophils: involvement of sphingomyelin metabolites in the priming effect of TNF-alpha on the fMLP-stimulated superoxide production |
| Q29041393 | Tumor necrosis factor- induces adhesion molecule expression through the sphingosine kinase pathway |
| Q35264010 | Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde |
| Q44109350 | Two forms of membrane-bound sphingosine kinase in Tetrahymena and activity changes during growth and the cell cycle |
| Q41113014 | Understanding and controlling the cell cycle with natural products |
| Q38625631 | Unravelling the interplay of sphingolipids and TGF-β signaling in the human corneal stroma |
| Q47734379 | Vasoactive intestinal peptide induces both tyrosine hydroxylase activity and tetrahydrobiopterin biosynthesis in PC12 cells |
Search more.